Northern State Medical University Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2004
NCT00159510
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Northern State Medical University

Active Ingredients

Drugs in Phase 3 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Phase 1 Trials (2)

methylene blue (proveblue) (1 trial)

nitric oxide (inomax) (1 trial)

Drugs in Other Trials (3)

propofol (diprivan) (1 trial)

sevoflurane (ultane) (1 trial)

Sextaphag (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 1)

Lung Injury (Phase 1)

Opioid-Related Disorders (Phase 3)

Respiratory Distress Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6